OR WAIT null SECS
February 05, 2024
The CDMOs are joining together to offer end-to-end development and manufacturing services for protein expression systems and viral vectors in Europe.
Novo Holdings has entered into a merger agreement with Catalent and will acquire Catalent in a deal valued at $16.5 billion.
February 03, 2024
ProductLife Group has announced its acquisition of Australian company Commercial Eyes.
February 02, 2024
Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.
Agilent Technologies and Incyte have signed an agreement to collaborate on the development of companion diagnostics programs.
January 26, 2024
Getinge has announced the inauguration of its new Global Centre of Excellence for Chemistry in the United Kingdom
January 24, 2024
Under a new alliance, KBI Biopharma and Argonaut Manufacturing Services will combine their strengths to offer end-to-end biopharma development and CGMP manufacturing solutions.
January 22, 2024
Abzena has launched its AbZelect platforms, designed for improving cell line development.
January 18, 2024
The acquisition will give Novartis full rights to CALY-002, Calypso’s lead product candidate.
January 17, 2024
Charles River’s off-the-shelf rep/cap plasmids are intended to simplify gene therapy supply chains.